We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
Nε-(ϒ-L-glutamyl)-L-lysine isopeptide antibody (81D1C2)
Ne (acetyl) lysine
Isopeptide
Isopeptide
As low as
€278.30
In stock
Ref
00012720
Nε-(ϒ-L-glutamyl)-L-lysine isopeptide antibody (81D1C2)
| ID Covalab | mab0011-P |
|---|---|
| Product type | Primary antibodies |
| Clonality | Monoclonal antibody |
| Clone | 81D1C2 |
| Isotype | IgG1 / Kappa |
| Raised in | Mouse |
| Immunogen | Nε-(ϒ-L-glutamyl)-L-lysine isopeptide |
| Activity cross reaction | Reacts with the Ne (g -L-glutamyl)-L-lysine isopeptide. Cross reacts strongly with Ne acetyl lysine. |
| Species | All Sp. |
| Labelling | None |
| Form | Purified (protein A) |
| Preservative | None |
| Storage instructions | Lyophilized powder stable for a minimum of 2 years at -20°C. Store reconstituted antibodies at +4°C. For extended periods store in aliquots at -20°C. Antibodies are guaranteed for 6 month from date of receipt. |
| Target | Nε-(ϒ-L-glutamyl)-L-lysine isopeptide |
| Applications | ELISA, IF, IHC, WB |
| Working dilutions | Optimal dilution should be determined by the end user. The following are guidelines only : IHC (1:50 - 1:1000) |
| Publication | * Maiuri L et al. J Immunol. 2008 Jun 1,180(11):7697-705. (WB, Hu) * Thomas V et al. J Immunol Methods. 2004 Sep,292(1-2):83-95. * Johnson G.V. & R. LeShoure. J Neurosci Methods. 2004 Apr 30,134(2):151-8. * Junn E. et al. Proc Natl Acad Sci U S A. 2003 Feb 18,100(4):2047-52. (IHC-human) * Citron BA et al. Neurochem Int. 2002 Jan;40(1):69-78. * Hirao T et al. Exp Dermatol. 2001 Feb,10(1):35-44. * el Alaoui S et al. Int J Cancer. 1991 May10,48(2):221-6. * Roch AM et al. Int J Cancer. 1991 May10,48(2):215-20. |
Write Your Own Review